Kimya & İlaç — NORDIC Sektör Analizi

Total Market Cap 47.9B

P/E (Weighted)Price to Earnings ratio. 14.00 Medyan: 14.00

P/B (Weighted)Price to Book ratio. 1.88 Medyan: 1.83

P/E (Arithmetic)Simple average P/E. 4.01

Avg Lothien ScoreFinancial health score (0-100). 70

Avg DamodaranDamodaran scoring model. 53

Avg PotentialExpected upside potential %. +77.7%

Avg Dalio ScoreDalio debt cycle score. 68

Distributions

Lothien Distribution

0–25

25–40

40–55

55–70

70–100

Damodaran Distribution

0–25

25–40

40–55

55–70

70–100

Upside Potential

-100% – -20%

-20% – +0%

+0% – +20%

+20% – +50%

+50%+

Stocks in Sector

Stock	PriceCurrent trading price.	Market CapTotal market capitalization.	FKPrice to Earnings ratio.	PD/DDPrice to Book ratio.	EV/EBITDAEnterprise Value / EBITDA.	ROICReturn on Invested Capital.	WACCWeighted Average Cost of Capital (WACC).	PUSLAFinancial health score (0-100).	DamodaranValuation score.	Intrinsic ValueFair value via DCF model.	Potential %Expected upside potential %.	Dalio RiskDalio Debt Cycle Score	Debt/EquityDebt to Equity ratio.
HPOL_B	89.00	29.3B	4.01	2.13	2.60	11.9%	8.7%	78	61	189.75	+84.9%	71	0.39
BILL	74.55	18.5B	—	0.68	2.37	-0.5%	7.9%	62	46	168.49	+70.6%	65	0.28